This webinar will cover some of the key aspects of cancer-associated thrombosis (CAT), such as:

• The burden of VTE in cancer patients
• Risk assessment tools that can be employed in patients with cancer which need to be followed by appropriate thromboprophylaxis to reduce the VTE risk
• Selection of the right agent with consideration to balance the competing risks of bleeding and thrombosis
• Updates on guideline recommendations for the management of different clinical scenarios associated with cancer-associated thrombosis